References
- Wilson TA, Rose SR, Cohen P, Rogol AD, Backeljauw P, Brown R, et al. The Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. Update of guidelines for the use of growth hormone in children : the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr 2003;143:415-21 https://doi.org/10.1067/S0022-3476(03)00246-4
- Gharib H, Cook DM, Saenger PH, Bengtsson BA, Feld S, Nippoldt TB, et al. American Association of Clinical Endocrinologists Growth Hormone Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children--2003 update. Endocr Pract 2003;9:64-76 https://doi.org/10.4158/EP.9.1.64
- Cutfield W, Lindberg A, Albertsson-Wikland K, Chatelain P, Ranke MB, Wilton P. Final height in idiopathic growth hormone deficiency : the KIGS experience. KIGS International Board. Acta Paediatr Suppl 1999;88:72-5
- Gleeson HK, Shalet SM. The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours. Endocr Relat Cancer 2004;11:589-602 https://doi.org/10.1677/erc.1.00779
- Harris M, Hofman PL, Cutfield WS. Growth hormone treatment in children : review of safety and efficacy. Paediatr Drugs 2004;6:93-106 https://doi.org/10.2165/00148581-200406020-00003
- Shin JH, Ko CW, Kim DH, Kim JD, Kim HS, Kim HS, et al. Spontaneous growth in Korean patients with Turner syndrome. J Korean Soc Pediatr Endocrinol 1998;3:1-6
- Haeusler G, Schmitt K, Blumel P, Plochl E, Waldhor T, Frisch H. Growth hormone in combination with anabolic steroids in patients with Turner syndrome : effect on bone maturation and final height. Acta Paediatr 1996;85:1408-14
- Saenger P, Wikland KA, Conway GS, Davenport M, Gravholt CH, Hintz R, et al. Fifth International Symposium on Turner Syndrome. Recommendations for the diagnosis and management of Turner syndrome. J Clin Endocrinol Metab 2001;86:3061-9 https://doi.org/10.1210/jc.86.7.3061
- Rosenfield RL, Devine N, Hunold JJ, Mauras N, Moshang T Jr, Root AW. Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome. J Clin Endocrinol Metab 2005;90:6424-30 https://doi.org/10.1210/jc.2005-1081
- Rizzoni G, Broyer M, Brunner FP, Brynger H, Challah S, Kramer P, et al. Combined report on regular dialysis and transplantation of children in Europe, XIII, 1983. Proc Eur Dial Transplant Assoc Eur Ren Assoc 1985;21:66-95
- Rabkin R, Sun DF, Chen Y, Tan J, Schaefer F. Growth hormone resistance in uremia, a role for impaired JAK/ STAT signaling. Pediatr Nephrol 2005;20:313-8 https://doi.org/10.1007/s00467-004-1713-8
- van Diemen-Steenvoorde R, Donckerwolcke RA, Brackel H, Wolff ED, de Jong MC. Growth and sexual maturation in children after kidney transplantation. J Pediatr 1987;110: 351-6
- Vimalachandra D, Craig JC, Cowell CT, Knight JF. Growth hormone treatment in children with chronic renal failure : a meta-analysis of randomized controlled trials. J Pediatr 2001;139:560-7 https://doi.org/10.1067/mpd.2001.117582
- Kari JA, Rees L. Growth hormone for children with chronic renal failure and on dialysis. Pediatr Nephrol 2005;20: 618-21 https://doi.org/10.1007/s00467-004-1801-9
- Haffner D, Schaefer F, Nissel R, Wuhl E, Tonshoff B, Mehls O. Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. N Engl J Med 2000;343:923-30 https://doi.org/10.1056/NEJM200009283431304
- Fine RN. Growth post renal-transplantation in children : lessons from the North American Pediatric Renal Transplant Cooperative Study(NAPRTCS). Pediatr Transplant 1997;1:85-9
- Fine RN, Ho M, Tejani A. North American Pediatric Renal Trasplant Cooperative Study(NAPRTCS). The contribution of renal transplantation to final adult height : a report of the North American Pediatric Renal Transplant Cooperative Study(NAPRTCS). Pediatr Nephrol 2001;16:951-6 https://doi.org/10.1007/s004670100002
- Fine RN, Sullivan EK, Kuntze J, Blethen S, Kohaut E. The impact of recombinant human growth hormone treatment during chronic renal insufficiency on renal transplant recipients. J Pediatr 2000;136:376-82 https://doi.org/10.1067/mpd.2000.103850
- Mehls O, Wilton P, Lilien M, Berg U, Broyer M, Rizzoni G, et al. Does growth hormone treatment affect the risk of post-transplant renal cancer? Pediatr Nephrol 2002;17:984-9 https://doi.org/10.1007/s00467-002-0962-7
- Albertsson-Wikland K, Karlberg J. Natural growth in children born small for gestational age with and without catch-up growth. Acta Paediatr Suppl 1994;399:64-70
- Lee PA, Chernausek SD, Hokken-Koelega AC, Czernichow P. International Small for Gestational Age Advisory Board. International Small for Gestational Age Advisory Board consensus development conference statement : management of short children born small for gestational age, April 24- October 1, 2001. Pediatrics 2003;111:1253-61 https://doi.org/10.1542/peds.111.6.1253
- Tanner JM, Lejarraga H, Cameron N. The natural history of the Silver-Russell syndrome : a longitudinal study of thirty-nine cases. Pediatr Res 1975;9:611-23 https://doi.org/10.1203/00006450-197508000-00001
- Hokken-Koelega AC. Timing of puberty and fetal growth. Best Pract Res Clin Endocrinol Metab 2002;16:65-71 https://doi.org/10.1053/beem.2002.0181
- Lazar L, Pollak U, Kalter-Leibovici O, Pertzelan A, Phillip M. Pubertal course of persistently short children born small for gestational age(SGA) compared with idiopathic short children born appropriate for gestational age(AGA). Eur J Endocrinol 2003;149:425-32 https://doi.org/10.1530/eje.0.1490425
- Johnston LB, Savage MO. Should recombinant human growth hormone therapy be used in short small for gestational age children? Arch Dis Child 2004;89:740-4 https://doi.org/10.1136/adc.2003.034785
- Van Dijk M, Mulder P, Houdijk M, Mulder J, Noordam K, Odink RJ, et al. High serum levels of growth hormone(GH) and insulin-like growth factor-I(IGF-I) during high-dose GH treatment in short children born small for gestational age. J Clin Endocrinol Metab 2006;91:1390-6 https://doi.org/10.1210/jc.2005-1663
- Van Pareren Y, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A. Adult height after long-term, continuous growth hormone(GH) treatment in short children born small for gestational age : results of a randomized, double-blind, dose-response GH trial. J Clin Endocrinol Metab 2003;88:3584-90 https://doi.org/10.1210/jc.2002-021172
- Ong K, Beardsall K, de Zegher F. Growth hormone therapy in short children born small for gestational age. Early Hum Dev 2005;81:973-80 https://doi.org/10.1016/j.earlhumdev.2005.10.010
- de Zegher F, Hokken-Koelega A. Growth hormone therapy for children born small for gestational age : height gain is less dose dependent over the long term than over the short term. Pediatrics 2005;115:e458-62 https://doi.org/10.1542/peds.2004-1934
- Boonstra V, van Pareren Y, Mulder P, Hokken-Koelega A. Puberty in growth hormone-treated children born small for gestational age(SGA). J Clin Endocrinol Metab 2003;88: 5753-8 https://doi.org/10.1210/jc.2003-030512
- Gubitosi-Klug RA, Cuttler L. Idiopathic short stature. Endocrinol Metab Clin North Am 2005;34:565-80 https://doi.org/10.1016/j.ecl.2005.04.003
- Kemp SF, Kuntze J, Attie KM, Maneatis T, Butler S, Frane J, et al. Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature. J Clin Endocrinol Metab 2005;90:5247-53 https://doi.org/10.1210/jc.2004-2513
- Finkelstein BS, Imperiale TF, Speroff T, Marrero U, Radcliffe DJ, Cuttler L. Effect of growth hormone therapy on height in children with idiopathic short stature : a metaanalysis. Arch Pediatr Adolesc Med 2002;156:230-40 https://doi.org/10.1001/archpedi.156.3.230
- Wit JM, Rekers-Mombarg LT, Cutler GB, Crowe B, Beck TJ, Roberts K, et al. Growth hormone(GH) treatment to final height in children with idiopathic short stature : evidence for a dose effect. J Pediatr 2005;146:45-53 https://doi.org/10.1016/j.jpeds.2004.08.055
- Freemark M. Editorial : Growth hormone treatment of 'idiopathic short stature' : not so fast. J Clin Endocrinol Metab 2004;89:3138-9 https://doi.org/10.1210/jc.2004-0671
- Kemp SF, Kuntze J, Attie KM, Maneatis T, Butler S, Frane J, et al. Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature. J Clin Endocrinol Metab 2005;90:5247-53 https://doi.org/10.1210/jc.2004-2513
- Yanovski JA, Rose SR, Municchi G, Pescovitz OH, Hill SC, Cassorla FG, et al. Treatment with a luteinizing hormonereleasing hormone agonist in adolescents with short stature. N Engl J Med 2003;348:908-17 https://doi.org/10.1056/NEJMoa013555
- Lindgren AC, Ritzen EM. Five years of growth hormone treatment in children with Prader-Willi syndrome. Swedish National Growth Hormone Advisory Group. Acta Paediatr Suppl 1999;88:109-11 https://doi.org/10.1111/j.1651-2227.1999.tb14416.x
- Carrel AL, Myers SE, Whitman BY, Allen DB. Benefits of long-term GH therapy in Prader-Willi syndrome : a 4-year study. J Clin Endocrinol Metab 2002;87:1581-5 https://doi.org/10.1210/jc.87.4.1581
- Wilson SS, Cotterill AM, Harris MA. Growth hormone and respiratory compromise in Prader-Willi syndrome. Arch Dis Child 2006;91:349-50 https://doi.org/10.1136/adc.2005.086090
- Eiholzer U. Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS. Horm Res 2005; 63:33-9 https://doi.org/10.1159/000082745
- Sklar CA, Mertens AC, Mitby P, Occhiogrosso G, Qin J, Heller G, et al. Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone : a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2002;87:3136-41 https://doi.org/10.1210/jc.87.7.3136